121 related articles for article (PubMed ID: 2142274)
1. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Meyran M; Joly B; Derlot E; Morel C
Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Morel C; Acar JF; Thabaut A; Fleurette J; Vallée E; Dabernat H; Chanal M; Drugeon H
Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
Soussy CJ; Deforges L; Le Van Thoi J; Thabaut A; Meyran M; Chanal M; Cluzel M; Brun Y; Coulet M; Fleurette J
Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve].
Soussy CJ; Cluzel M; Derlot E; Kitzis MD; Meyran M
Pathol Biol (Paris); 1994 May; 42(5):385-92. PubMed ID: 7824301
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].
Soussy CJ; Duval J; Chanal M; Sirot D; Bergogne-Bérézin E; Joly-Guillou ML; Malbruny B; Morel C
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].
Soussy CJ; Morel C; Kitzis MD; Meyran M; Brun Y; Joly-Guillou ML; Dabernat H; Chanal M; Courtieu AL; Derlot E
Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670
[TBL] [Abstract][Full Text] [Related]
11. Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
Davila D; Tambić T; Djokić S; Kolacny-Babić L
Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of imipenem against hospital bacteria].
Soussy CJ; Duval J
Presse Med; 1990 Apr; 19(13):583-7. PubMed ID: 2139936
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P
Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711
[TBL] [Abstract][Full Text] [Related]
14. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].
Soussy CJ; Cluzel M; Derlot E; Exmelin L; Kitzis MD; Dabernat H; Le Noc P; Muller-Serieys C; Reverdy ME; Scheftel JM; Thabaut A
Pathol Biol (Paris); 1996 Apr; 44(4):241-8. PubMed ID: 8763585
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin and azithromycin: new macrolide antibiotics.
Piscitelli SC; Danziger LH; Rodvold KA
Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
